A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma: An Eastern Cooperative Oncology Group study (E5292)

Cancer

Volumn 85, Issue 2, 1999, Pages 290-294

  Hudes, Gary R ^a   Lipsitz, Stuart ^b   Grem, Jean ^c   Morrisey, Mary ^b   Weiner, Louis ^a   Kugler, John W ^d   Benson III, Al ^e  

^a FOX CHASE CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Illinois Oncology Research Association   (United States)

^e NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 fluorouracil; Chemotherapy; Gastric carcinoma; Interferon

Indexed keywords

FLUOROURACIL; FOLINIC ACID; RECOMBINANT ALPHA2B INTERFERON;

ADENOCARCINOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOTHERAPY; DIARRHEA; FLU LIKE SYNDROME; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; STOMACH CARCINOMA; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0032942269     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<290::AID-CNCR4>3.0.CO;2-P     Document Type: Article

References (14)

1. Fuchs CS, Mayer R. Gastric carcinoma. N Engl J Med 1995; 333:32-41.
2. Comis RL, Carter SR. A review of chemotherapy in gastric cancer. Cancer 1974;34:1576-86.
3. Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
4. Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, et al. Fluorouracil and recombinant Alfa-2a-Interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 1989;7:1769-75.
5. Grem JL, McAtee N, Murphy RF, Balis FM, Steinberg SM, Hamilton JM, et al. A pilot study of interferon alfa-2a in combination with 5-fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol 1991; 9:1811-20.
6. Grem JL, Jordon ME, Binder RA, Hamilton JM, Steinberg SM, Arbuck SG, et al. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma. J Clin Oncol 1993;11:1737-45.
7. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991;9:449-52.
8. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity response criteria of the eastern cooperative oncology group. Am J Clin Oncol (CCT) 1982;5: 649-55.
9. Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1986;4:685-96.
10. Arbuck SG, Douglass HO, Trave F, Milliron S, Baroni M, Nava H, et al. A phase-II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 1987;5:1150-6.
11. Berenberg JL, Tangen C, Macdonald JS, Hutchins LF, Natale RB, Oishi N, et al. Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. Cancer 1995;76:715-9.
12. Rubin J, Gallagher JG, Schroeder G, Schutt AJ, Dalton RJ, Kugler JW, et al. Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer 1996;77:1888-91.
13. Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, et al. A phase II trial of 5-fluorouracil and recombinant Alpha-2a-interferon in previously untreated metastatic gastric carcinoma. Cancer 1992;69:878-82.
14. Jäger E, Bernhard H, Klein O, Wächter B, Theiss F, Dippold W, et al. Combination 5-fluorouracil (FU), folinic acid (FA) and a-interferon 2B in advanced gastric cancer: results of a phase II trial. Ann Oncol 1995;6:153-6.